Navigation Links
Tasker Products Receives USDA Authorization to Begin Commercialization of its Post-Chill Spray Application
Date:6/23/2008

FAIR LAWN, N.J., June 23 /PRNewswire-FirstCall/ -- Tasker Products Corp. (OTC Bulletin Board: TKER), a distributor and marketer of proprietary technology effective in inhibiting pathogenic bacteria, today announced that it has received authorization from the United States Food and Drug Administration ("USDA") to market its post-chill spray application, which will be used immediately after the Chill process in poultry processing plants to further eradicate pathogenic bacteria prior to packaging.

Poultry carcasses are run through a chilling tank to reduce their temperatures to approximately 40 degrees Fahrenheit (or less) to inhibit microscopic spoilage. Chlorine is used in the chilling tank water to destroy bacteria; however, due to the low temperature, solids form reducing the Chlorine's effectiveness in eradicating bacteria. Tasker's post-chill spray using Tasker Blue is highly effective at eradicating bacteria. The Company is also in the process of conducting USDA tests of a post-chill dip and is seeking USDA approval to market its Tasker Blue in the Chiller section.

Tests of Tasker Blue at various intervention points of poultry processing in three separate processing plants indicated that it had a significant and dramatic impact on aerobic plate count ("APC") and E. coli numbers on chicken carcasses to levels not currently attainable with any competing products.

Tasker Blue's ingredients are Generally Recognized as Safe ("GRAS") by the USDA, it does not gas-off (reducing workers' exposure to potentially hazardous fumes), and it poses no organoleptic damage across a broad range of pH concentrations and exposure times.

"We currently market Tasker Blue for use in the scalder, picker and post-picker intervention points. In addition to adding the post-chill spray, we expect to achieve USDA authorization to market Tasker Blue for the chiller section and as a post-chill dip," said Lanny Dacus, Tasker's president and CEO, commenting on the news. "USDA testing policies that were scheduled to go into effect at the end of March, were postponed, which had an impact on our marketing strategy for the scalder application. Although a set date for the new testing policies to go into effect has not been posted, poultry processors are beginning to prepare for the event and, as a result, we are experiencing increased interest in our scalder application."

About Tasker Products

Tasker is a manufacturer, distributor and marketer of eco-chemistry products with various applications that use the pHarlo technology. The pHarlo technology utilizes a highly charged and acidified, yet stable and safe, solution that enables copper sulfate, a compound with bacteriostatic properties, to remain active throughout a wide range of pH values. The Company currently markets Unifresh(R) Footbath, a grooming aid product for dairy cows, Tasker Blue(R), an antibacterial solution for use in processing poultry and Pacific Blue(TM) Seafood Spray, an antibacterial spray for retail seafood counters. Tasker Products Corp. is headquartered in Fair Lawn, New Jersey. To be added to the news distribution list or to present any questions, send an email to tasker@grannusfinancial.com. Additional information about Tasker is also available at http://www.taskerproducts.com.

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to obtain new financing and/or generate revenue growth in the near future; our history of losses; our limited experience in the marketing of our products; our ability to compete with other products in our market space; and the risk of unfavorable federal regulation. Consequently, you should not place undue reliance on these forward-looking statements. We discuss these and other risks and uncertainties in greater detail in the filings we make with the Securities and Exchange Commission, including under the section entitled, "Risk Factors" in the Company's Annual Report on Form 10-K, as amended, for the year ended December 31, 2006 and our most recent report on Form 10-Q.

Company and Investor Contact:

Dorren J. Remmen

Chief Financial Officer

Tasker Products Corp.

201-475-7328

DRemmen@TaskerProducts.com


'/>"/>
SOURCE Tasker Products Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. When It comes to Matters of the Heart, Almonds Are a Multi-Tasker
2. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
3. Tasker Products Rolls Out Scalder Application at Two New Poultry Processors Facilities
4. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
5. American Dental Hygienists Association and Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. Unveil Honorees of Inaugural HYGIENIST HERO(TM) Recognition Program
6. Natural Nutrition Begins Exports of InterACTIVE Nutrition Brand Products to Pakistan
7. Plaintiffs Lawyer Orders Lead Testing on 3 Popular Herbalife Products; Results Show 728% More Lead Than Allowed by Law Under Proposition 65 Violation
8. Consumers Urged to Avoid Raw Milk and Raw Milk Products
9. Decline in Cigarette Sales Offset by Use of Alternative Products
10. NBTY Announces Agreement to Purchase Leiner Health Products
11. ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across ... Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return of ... focus area for hospitals across the nation. While many providers are struggling to leverage ...
(Date:2/17/2017)... ... 17, 2017 , ... The Mason Pasquin Agency, a Virginia-based ... owners in and around the Hampton Roads metropolitan region, is joining the local ... domestic violence. , There are multiple categories of domestic violence – physical abuse ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha ... 10 years of research, development and clinical trials, the founder of Chigurupati Technologies ... patented compound of FDA approved ingredients that when infused into alcohol, protect the ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
(Date:2/16/2017)... Mt. Kisco, New York (PRWEB) , ... February ... ... Westchester Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH ... Chair of the Commission on Magnet on Tuesday, January 31, 2017. The American ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 ... the S&P 500 edged lower at the closing bell, ... streak above the 20,000 benchmark. Moreover, five out of ... Taking into consideration yesterday,s market sentiment, Stock-Callers.com assessed the ... & Nephew PLC (NYSE: SNN ), ABIOMED ...
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... -- The global preparative and process chromatography market is ... USD 5.49 billion in 2016, at a CAGR of ... the preparative and process chromatography market is segmented into ... chromatography segment is expected to account for the largest ... in this segment can primarily be attributed to the ...
Breaking Medicine Technology: